Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublication section wording updated to clarify that PubMed publications may not be about the study and are automatically filled from PubMed. It also adds a revision note indicating version 3.3.2, replacing the previous version 3.2.0 wording.SummaryDifference0.2%

- Check20 days agoChange DetectedDeleted the government funding operating-status notice from the page.SummaryDifference0.1%

- Check27 days agoChange DetectedPublications section updated: added Lu H et al., Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction, JACC Heart Fail. 2025 Oct;13(10):102590 (doi:10.1016/j.jchf.2025.102590). The August 2025 Online ahead of print entry for the same article was removed.SummaryDifference0.0%

- Check34 days agoChange DetectedNo significant content changes were detected; core information about the trial remains unchanged, with minor UI and metadata updates observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study locations were updated: added Cali, Valle del Cauca Department, Colombia (760042) and removed Santiago de Cali, Valle del Cauca Department, Colombia (760042).SummaryDifference0.0%

- Check49 days agoChange DetectedNo significant changes detected. The added citation mirrors the deleted one with minor formatting/identifier differences; core information and meaning remain the same.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.